iECURE
Developer of an in vivo gene editing platform designed to create long-lasting treatments for patients with rare genetic liver disorders. The company's platform offers mutation-agnostic gene insertion ...
Valuation
$155M
Market implied
Share Price
N/A
Total Raised
$115M
Last Round
N/A